IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 187.50% | -- | -78.96% | -72.04% | -95.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 187.50% | -- | -78.96% | -72.04% | -95.05% |
| Cost of Revenue | -61.13% | -71.43% | -75.54% | -63.71% | 6.27% |
| Gross Profit | 66.27% | -125.00% | -84.21% | -86.67% | -84.15% |
| SG&A Expenses | -55.08% | -72.28% | -73.17% | -71.77% | -46.27% |
| Depreciation & Amortization | -95.10% | 135.48% | -87.27% | -63.87% | 179.17% |
| Other Operating Expenses | -54.22% | -18.95% | -7.78% | -20.81% | 9.43% |
| Total Operating Expenses | -65.29% | -51.80% | -50.85% | -49.19% | 2.64% |
| Operating Income | 66.31% | 51.09% | 49.04% | 47.77% | -11.58% |
| Income Before Tax | 27.23% | -172.94% | 68.31% | 23.58% | 21.64% |
| Income Tax Expenses | 100.00% | -- | -2,250.00% | -- | -913.33% |
| Earnings from Continuing Operations | 24.84% | -172.94% | 68.96% | 23.54% | 24.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.84% | -172.94% | 68.96% | 23.54% | 24.36% |
| EBIT | 66.31% | 51.09% | 49.04% | 47.77% | -11.58% |
| EBITDA | 61.02% | 51.60% | 40.41% | 46.58% | 17.39% |
| EPS Basic | 91.61% | -105.44% | 96.97% | 74.30% | 60.01% |
| Normalized Basic EPS | 100.64% | -105.42% | 96.91% | 98.93% | 38.73% |
| EPS Diluted | 91.21% | -105.49% | 96.94% | 75.09% | 59.99% |
| Normalized Diluted EPS | 100.64% | -105.43% | 96.91% | 98.93% | 38.47% |
| Average Basic Shares Outstanding | 795.57% | 1,244.44% | 924.96% | 197.45% | 89.17% |
| Average Diluted Shares Outstanding | 794.72% | 1,240.76% | 924.96% | 197.45% | 88.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |